Ideas to Action:

Independent research for global prosperity

The Future of Global Health Procurement

Many low-and lower-middle-income countries currently get a large portion of their health products—drugs, devices, diagnostics, and vector control tools— through centralized, donor-managed procurement mechanisms, and often at subsidized prices or as donations. Moreover, global health procurement needs are evolving rapidly as countries transition from donor aid, global disease burdens shift, and the organization of health systems transition from vertical disease programs to universal health coverage.

In this context, how can the global health community act now to ensure the medium- to-long-term efficiency, quality, affordability, and security of global health procurement? This question is the subject of a CGD Working Group; the final report is expected in Spring 2019.

Featured Work

Image of pile of pills
February 25, 2019
Michael Pisa and Denise McCurdy
July 10, 2018

In recent years, many global health institutions have adopted eligibility and transition frameworks for the countries they support, generating questions about how these frameworks apply in practice—and whether global health progress will be put at risk through premature or poorly planned transition processes.